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The occurrence of glomerulonephritis in schis-
tosomiasis has been documented over the past 10
years 11-4]. The presence of granular deposits of
immunoglobulin and complement in the glomeruli
suggests that they may be secondary to immune
complexes (IC). The formation of IC in the blood
can be expected from the simultaneous occurrence
in the circulation of parasitic antigens and the corre-
sponding antibodies. A limited number of studies
devoted either to human or experimental situations
have shown the presence of material behaving as IC
in helminthic infections, in some cases by radio-
labeled Clq assay, and in others by inhibition of
EAC rosette formation [5—7]. In a few patients, in-
direct evidence has been provided suggesting that
schistosomial antigens were present in the IC [7, 81.
In the present study, we have tested the sera of pa-
tients suffering from various parasitosis with the
sensitive Raji cell radioimmune assay [9]. We chose
this method because the immune complex bound to
the Raji cell surface is directly accessible to identifi-
cation of the antigenic moiety. Furthermore, the pa-
tients were clinically studied carefully for the pres-
ence of nephritis, and biologic evidence of com-
plement activation.
Methods
Patients. A total of 27 patients with schistoso-
miasis were studied. Thirteen had been infected
with Schistosoma haematobium and 14 with
Schistosoma mansoni. The diagnosis was estab-
lished by the detection of eggs in urine or fecal sam-
ples. In some patients, samples were obtained be-
fore and after treatment, which consisted of nirida-
zole at a dosage of 25 mg/kg for 7 days.
Twenty-eight patients had filariasis diagnosed by
the direct demonstration of microfilariae and sero-
logic techniques [10, 11]. The parasite involved was
Loa-Loa in 11 cases, Dracunculus medinensis in 7
cases, Wucheria bancrofti in 7 cases, and Oncho-
9
cerca volvulus in the remaining cases. Treatment,
except for 0. volvulus, relied on notezine for 7 days
at conventional dosages. Nineteen patients had
hydatidosis diagnosed by pathologic examination of
the surgically removed cyst and immunologic meth-
ods.
Immune complexes. Detection of immune com-
plexes was performed with the Raji cell radioassay
described by Theofilopoulos, Wilson, and Dixon [9]
with some modifications. Blood samples were col-
lected and were allowed to clot at 37° C for 1 hour.
The sera separated by centrifugation were stored in
aliquots at —70° C. Normal human serum samples
were obtained in a similar manner from normal
blood donors in Hópital Tenon and in Dakar's
transfusion centers. Briefly, 2 X 106 Raji cells were
incubated for 30 mm at 37° C with 25 d of 1/4 dilu-
tion of the serum to be tested. After three washings,
the cells were incubated with an excess of 1251 radio-
labeled protein A from Staphylococcus aureus
(Pharmacia Fine Chemical, France) [121. After three
washings, the cell pellets were counted in a gamma
counter. The final results were expressed in micro-
gram equivalents of IgG aggregated per milliliter of
serum by reference to a standard curve obtained by
incubation of known amounts of IgG aggregates in
normal human serum.
Complement measurements. For these studies,
blood samples were collected in EDTA at a final
concentration of 20 mmoles. The plasma was sepa-
rated by centrifugation and stored in aliquots at
—70° C. C3d concentrations were measured with
immunoprecipitation techniques as described ini-
tially by Perrin, Lambert, and Miescher [13]. Mono-
specific anti-C3d antiserum was purchased from the
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Netherland Red Cross (Amsterdam, The Nether-
lands) and used in a unidimensional Laurel tech-
nique. The results were expressed in micrograms
per milliliter by reference to a standard curve using
purified C3d. C3, C4, and properdin were measured
by standard radial immunodiffusion methods.
Complement activation by parasitic antigens. By
using techniques previously described [10, 11, 14],
we prepared crude parasitic antigens from S. man-
soni, D. medinensis, and 0. volvulus and dissolved
them in veronal buffered saline at a concentration of
1 mg/mi. We incubated 100 Mi of this solution with
400 Mi ofnormal serum for 30 mm at 37° C or 40° C.
Complement activation was assessed by measure-
ment of C3 conversion with crossed immuno-
electrophoresis and by measurement of C3 con-
sumption by hemolytic assay [15], after incubation
with the parasitic antigens from schistosomes and
fiiariae.
Results
Immune complexes. The results are presented in
Fig. 1. A limited number of sera were positive in
filariasis (36%) and schistosomiasis (24%). The de-
gree of positivity, however, was low, and none of
the results of these two groups reached statistical
significance when compared to those from a group
of normal sera by using the Mann Whitney U test.
C3d levels. The results are presented in Fig. 2. A
high percentage of positive results was found both
in S. mansoni (59%) and S. haematobium infection
(75%), and in some instances very high levels of
C3d could be detected. In filariasis also, and partic-
ularly in basis and lymphatic filariasis, abnormally
high levels of C3d were observed. C3, C4, and pro-
perdin levels were measured in nine patients who
had high C3d levels, and all were normal.
No correlation could be found between the pres-
ence of immune complexes and the levels of C3d.
Furthermore, neither of these two parameters could
be correlated clearly with any clinical or biologic
features of the disease, namely hypergammaglobu-
linemia, eosinophilia, duration, or activity of the
disease.
None of the patients with either IC or C3d pre-
sented with proteinuria or any other sign of renal
disease. Because it is known that therapeutic agents
can induce a release of parasitic antigens that
may affect immune complexes formation and com-
plement activation, these two parameters were
measured in some patients before and after treat-
ment. Figure 3 shows that marked variations of C3d
occurred but in a nonsystematic way, because a rise
occurred in some patients, whereas there was a fall
in the others. The levels of IC, by contrast, did not
change clearly, although this is more difficult to
evaluate because the amounts of IC detected in the
test were small.
Complement activation by parasitic antigens.
The results are presented in Table 1. It can be seen
that extracts from S. Mansoni were inactive, as in-
dicated by the lack of C3 conversion and the ab-
sence of any consumption of C3 hemolytic activity.
In contrast, extracts from D. medinensis produced
definite activation of complement indicated by C3
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Fig. 2. C3d levels in schistoso,niasis, filariasis, and hydatidosis.
volvulus extracts produced some complement acti-
vation but to a considerably lesser extent.
Discussion
Although parasitosis represents situations in
which the occurrence of IC is likely to occur at
some stage of the disease, they have not been yet
extensively investigated. In schistosomiasis and fil-
ariasis, IC have been demonstrated in a variable
percentage of patients by the Raji cell assay, the Clq
binding assay, and the inhibition of EAC rosettes.
The percentage of positive sera in the present se-
ries, measured with the Raji cell radioimmune as-
say, is comparable. The precise composition of the
material detected as IC is not known, but recent ob-
servations indicate that, at least in some cases,
parasitic antigens may be involved [7, 8]. There is,
at present, very little evidence to relate the material
detected as IC in the serum to the presence of gb-
merular disease. In the case of S. haematobium in-
fection, apart from a single series in Egypt [16], gb-
merulonephritis has not been clearly established, al-
though IC are found in some cases [5, 17].
Experimental studies also have failed to induce gb-
merular lesions. In contrast, in S. Mansoni infec-
tion in human, glomerubonephritis generally associ-
ated clinically with liver involvement has been well
demonstrated in various studies from Brazil. Histo-
logic examination revealed lesions ranging from a
mild glomerulosclerosis to diffuse membranoproli-
ferative glomerubonephritis [1-41. Granular immu-
noglobulin and complement could be demonstrated
in the glomerular deposits. More recently, parasite
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Table 1. Parasite antigens and complement activation




None 5 2.3 x IOH
Dracunculus medinensis
400 60 9 x 1010
100 50 l.6x 10"
50 40 ND
25 25 2.1 x loll
Onchocerca volvulus
400 10 ND
tOO 25 l.9x 10"
50 20 ND
25 10 2.2 x 10"
Schistosoma mansoni
400 5 2.2 x 1011
100 5 ND
50 5 ND
25 5 2.3 x 1011
a ND means not done.
antigens were found in a limited number of cases
[181, and it has been possible to demonstrate specif-
ic antischistosome antibody in the glomerular
eluates [19]. In experimental animals, infection with
S. Mansoni has led to the development of glomeru-
lonephritis. In mice [20] it has been possible to dem-
onstrate the presence of parasite antigens and anti-
schistosome antibody in the glomerular deposits.
More recent experiments in monkeys [211 suggest
that infection with large numbers of parasites can
give rise to glomerulonephritis. As in humans, the
presence of immunoglobulin and complement could
be demonstrated, but it was not possible to detect
the presence of schistosome antigen in the glomeru-
Ii by immunofluoresence, although it could be dem-
onstrated by counter-immunoelectrophoresis in kid-
ney homogenates [21].
In filariasis, glomerulonephritis has been de-
scribed very rarely, and no evidence has been pro-
vided to link the glomerular lesions to the parasitic
infection [22]. In periods following initiation of
treatment, serum sickness type reactions may be in-
duced, but glomerulonephritis apparently has not
been observed.
Discrepancies between the presence of circulat-
ing IC and the absence of glomerulonephnitis have
been noted previously [23], whereas, conversely, in
most instances of primary glomerulonephritis com-
patible with IC deposition, circulating IC can be de-
tected only with difficulty except for cases of acute
proliferative glomerulonephritis. Several hypothe-
ses can be put forward to explain these observa-
tions. It is possible that complexes measured by the
present techniques are unrelated to immune neph-
ntis, and new technologies may provide further insight
[24]. It is also possible, however, that the granular
deposits of Ig found in the glomeruli are not second-
ary to the deposition of IC formed in the blood but
rather to the local formation of IC through binding
of a circulating antibody to an antigen previously
deposited in the glomeruli. A number of models of
this type have recently been described [25, 261. Ex-
perimental evidence with S. mansoni infection in
baboons actually suggests that such a mechanism
could be operative because schistosome antigens
can be detected in cortex extracts before glomerular
deposition of Ig [211.
It is interesting to note that whereas low levels of
IC were found, C3 fragments were detected very
frequently in abnormally high amounts. This lack of
correlation suggested that parasitic antigens, which
are probably very abundant in vivo (and in some
instances may circulate within the blood stream),
could be directly responsible for complement acti-
vation. We could not support this hypothesis be-
cause the parasitic antigen preparations that we
used were unable to activate complement in vitro
except forD. medinensis, which is responsible for a
parasitosis in which we could not demonstrate C3d
in vivo. This may be due to the very localized life-
cycle of this worm. Alternatively, it could be pro-
posed that IC are indeed formed but remain local-
ized in the extravascular space or bound to fixed
structures. Direct complement activation by para-
site antigens cannot be ruled out, however, because
the preparation of antigens used in vitro may not
contain the potentially active fractions. In schis-
tosomiasis, a wide variety of antigens have been
identified [27], and only some of them may be ac-
tive. Furthermore, in vivo, one should consider also
the possibility that the antigens may change in
structure, either by a mechanism of adaptation to
the host [14] or by a variation of their surface, as
has been shown in trypanosomiasis [28]. Whatever
the cause of the complement activation, it did not
induce hypocomplementemia because levels of C3,
C4, and properdin in nine patients who had high C3
values were within normal limits. The observations
should be considered in the light of previous studies
based on turnover of C3 in hypocomplementemic
diseases, which show that an increased catabolism
is almost invariably associated with decreased syn-
thesis [29]. On the other hand, previous work in-
dicates that complement synthesis in inflammatory
conditions, as in some instances of liver disease
(which are likely to occur in some of our patients),
may be increased [30, 31]. In some instances of
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chronic active hepatitis, C3 split products may be
found in the serum with concomitant increased C
levels [321. The results obtained in our patients may
therefore be explained by hypercatabolism occur-
ring in patients with increased synthesis. Studies
along this line are at present in progress.
In conclusion, further work is required to estab-
lish the relationship between the immunologic ab-
normalities found in parasitic infections and the oc-
currence of glomerulonephritis. Studies on the me-
tabolism of parasite antigens and the immunologic
response that they induce will provide new insights.
Summary
Using the Raji cell radioimmune assay, we found
low levels of circulating immune complexes (IC) in
a small percentage of patients with schistosomiasis
and filariasis. C3d levels, measured by immuno-
precipitation, were elevated in a large number of
these patients, whereas complement levels were
within normal limits. Proteinuria was not found in
any of the 55 patients studied. Circulating IC or ele-
vated C3d levels were not found in any of the 19
patients with hydatidosis. The increased C3d levels,
apparently not related to circulating IC, may be due
to direct complement activation by parasite anti-
gens or to sequestered IC. The latter hypothesis ap-
pears more attractive because the highest levels of
C3d were found in schistosomiasis whereas schisto-
some antigens were unable to activate complement
in vitro.
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